Recent Small-Molecule Inhibitors of the p53–MDM2 Protein–Protein Interaction
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Recent Small-Molecule Inhibitors of the p53–MDM2 Protein–Protein Interaction
Authors
Keywords
-
Journal
MOLECULES
Volume 25, Issue 5, Pages 1211
Publisher
MDPI AG
Online
2020-03-09
DOI
10.3390/molecules25051211
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Design of indole- and MCR-based macrocycles as p53-MDM2 antagonists
- (2019) Constantinos G Neochoritis et al. Beilstein Journal of Organic Chemistry
- Design and synthesis of new substituted spirooxindoles as potential inhibitors of the MDM2–p53 interaction
- (2019) Assem Barakat et al. BIOORGANIC CHEMISTRY
- Synthesis of dispirooxindoles containing N-unsubstituted heterocyclic moieties and study of their anticancer activity
- (2019) A. A. Beloglazkina et al. RUSSIAN CHEMICAL BULLETIN
- Synthesis of new thiazolo-pyrrolidine–(spirooxindole) tethered to 3-acylindole as anticancer agents
- (2018) Mohammad Shahidul Islam et al. BIOORGANIC CHEMISTRY
- p53-Mdm2 Interaction Inhibitors as Novel Nongenotoxic Anticancer Agents
- (2017) Surendra Kumar Nayak et al. CURRENT CANCER DRUG TARGETS
- Discovery of Novel Spiro[3H-indole-3,2′-pyrrolidin]-2(1H)-one Compounds as Chemically Stable and Orally Active Inhibitors of the MDM2–p53 Interaction
- (2016) Andreas Gollner et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of Novel 3,3-Disubstituted Piperidines as Orally Bioavailable, Potent, and Efficacious HDM2-p53 Inhibitors
- (2016) Stéphane L. Bogen et al. ACS Medicinal Chemistry Letters
- Design, synthesis and biological evaluation of novel potent MDM2/p53 small-molecule inhibitors
- (2015) Yan A. Ivanenkov et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Discovery of dihydroisoquinolinone derivatives as novel inhibitors of the p53–MDM2 interaction with a distinct binding mode
- (2015) François Gessier et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- How To Design a Successful p53-MDM2/X Interaction Inhibitor: A Thorough Overview Based on Crystal Structures
- (2015) Natalia Estrada-Ortiz et al. ChemMedChem
- Discovery of a Dihydroisoquinolinone Derivative (NVP-CGM097): A Highly Potent and Selective MDM2 Inhibitor Undergoing Phase 1 Clinical Trials in p53wt Tumors
- (2015) Philipp Holzer et al. JOURNAL OF MEDICINAL CHEMISTRY
- Tetra-substituted imidazoles as a new class of inhibitors of the p53–MDM2 interaction
- (2014) Andrea Vaupel et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Discovery of AMG 232, a Potent, Selective, and Orally Bioavailable MDM2–p53 Inhibitor in Clinical Development
- (2014) Daqing Sun et al. JOURNAL OF MEDICINAL CHEMISTRY
- Targeting p53 for Novel Anticancer Therapy
- (2014) Zhen Wang et al. Translational Oncology
- Synthesis and evaluation of novel orally active p53–MDM2 interaction inhibitors
- (2013) Masaki Miyazaki et al. BIOORGANIC & MEDICINAL CHEMISTRY
- A Potent Small-Molecule Inhibitor of the MDM2–p53 Interaction (MI-888) Achieved Complete and Durable Tumor Regression in Mice
- (2013) Yujun Zhao et al. JOURNAL OF MEDICINAL CHEMISTRY
- P53 Mdm2 Inhibitors
- (2012) Kareem Khoury et al. CURRENT PHARMACEUTICAL DESIGN
- An Expeditious Synthesis of the MDM2–p53 Inhibitor AM-8553
- (2012) Brian S. Lucas et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- The Structure-Based Design of Mdm2/Mdmx-p53 Inhibitors Gets Serious
- (2011) Grzegorz M. Popowicz et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Exhaustive Fluorine Scanning toward Potent p53-Mdm2 Antagonists
- (2011) Yijun Huang et al. ChemMedChem
- Catalytic, enantioselective synthesis of stilbene cis-diamines: A concise preparation of (−)-Nutlin-3, a potent p53/MDM2 inhibitor
- (2011) Tyler A. Davis et al. Chemical Science
- Improvement of the synthesis and pharmacokinetic properties of chromenotriazolopyrimidine MDM2-p53 protein-protein inhibitors
- (2010) Hilary P. Beck et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Structures of low molecular weight inhibitors bound to MDMX and MDM2 reveal new approaches for p53-MDMX/MDM2 antagonist drug discovery
- (2010) Grzegorz M. Popowicz et al. CELL CYCLE
- 1,4-Thienodiazepine-2,5-diones via MCR (I): Synthesis, Virtual Space and p53-Mdm2 Activity
- (2010) Yijun Huang et al. Chemical Biology & Drug Design
- Reactivation of p53 by a specific MDM2 antagonist (MI-43) leads to p21-mediated cell cycle arrest and selective cell death in colon cancer
- (2008) Sanjeev Shangary et al. MOLECULAR CANCER THERAPEUTICS
- p53: The Janus of autophagy?
- (2008) Beth Levine et al. NATURE CELL BIOLOGY
- Transcriptional control of human p53-regulated genes
- (2008) Todd Riley et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Temporal activation of p53 by a specific MDM2 inhibitor is selectively toxic to tumors and leads to complete tumor growth inhibition
- (2008) S. Shangary et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started